Compare StocksABBV vs HCA

AbbVie Inc. (ABBV) vs HCA Healthcare, Inc. (HCA)

ABBV
AbbVie Inc.
$206.23
VS
HCA
HCA Healthcare, Inc.
$499.65

Rewards

ABBV
  • AbbVie Inc. has maintained ROIC above 10% for 4 consecutive years, suggesting solid business economics.
  • Gross margin of 71.6% indicates strong pricing power — typical of businesses with significant intellectual property or brand strength.
  • AbbVie Inc. scores 83/100 on the Economic Moat Score (Wide Moat), with reinvestment efficiency as the strongest competitive dimension.
HCA
  • HCA Healthcare, Inc. has maintained ROIC above 15% for 4 consecutive years, indicating a durable competitive advantage.
  • HCA Healthcare, Inc. scores 95/100 on the Economic Moat Score (Wide Moat), with roic consistency as the strongest competitive dimension.
  • Free cash flow has grown at a 23.1% CAGR over the past 4 years, demonstrating strong earnings power growth.

Risks

ABBV
  • Buybacks have been poorly timed — 3 out of 4 years involved repurchases at relatively expensive valuations.
  • FCF yield of 5.0% suggests reasonable valuation assuming continued moderate growth.
  • Trailing P/E of 87.0x is 39% above the historical average of 62.5x — the stock trades at a premium to its own history.
HCA
  • FCF yield of 6.9% suggests reasonable valuation assuming continued moderate growth.
  • Trailing P/E of 17.6x is 29% above the historical average of 13.6x — the stock trades at a premium to its own history.
  • 5 insider sales totaling $29.3M with no purchases in the past 3 months — insiders are reducing their exposure.

Key Valuation Metrics

Learn more →
ABBV
HCA
Valuation
$18.34B
Free Cash Flow
$7.69B
5.03%
FCF Yield
6.88%
87.02
Trailing P/E
17.64
12.80
Forward P/E
15.02
Quality & Moat
24.09%
ROIC
19.98%
N/A
ROE
N/A
71.62%
Gross Margin
41.50%
N/A
PEG Ratio
0.40
Balance Sheet Safety
N/A
Debt / Equity
N/A
N/A
Interest Coverage
N/A
2.16
Net Debt / EBITDA
3.07
3.36%
Dividend Yield
0.62%
ABBV: 6Ties: 1HCA: 2
ABBVHCA

Historical Fundamentals

Learn more →
ABBV

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation.

HCA

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation.

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation.

$1 Retained Earnings Test

Learn more →
ABBV
N/A
Net losses over 3 years — test not applicable
Company had negative cumulative retained earnings
Σ Retained
$-19.85B
Δ Market Cap
+$118.02B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer
HCA
$2.43
created per $1 retained over 3 years
Exceptional Value Creator
Σ Retained
$15.76B
Δ Market Cap
+$38.30B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Discounted Cash Flow (DCF) Analysis

Learn more →
ABBV
694.9% Overvalued
Price is 694.9% above estimated fair value
Current Price: $206.23
Fair Value: $25.94
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued
HCA
3.7% Margin of Safety
Price is 3.7% below estimated fair value
Current Price: $499.65
Fair Value: $519.03
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued

Reverse DCF — Market-Implied Growth

Learn more →
ABBV

What growth rate is the market pricing in at $206?

+30.1%
Market-Implied Owner Earnings Growth
Standard FCF implies +9.8%

The market implies +30.1% Owner Earnings growth, above historical trends.

Standard FCF implies a demanding +9.8%, reflecting heavy growth investment.

HCA

What growth rate is the market pricing in at $500?

+9.9%
Market-Implied Owner Earnings Growth
Standard FCF implies +8.2%

The market implies +9.9% Owner Earnings growth, above historical trends.

Standard FCF implies a demanding +8.2%, reflecting heavy growth investment.

Economic Moat Score

Learn more →
ABBV
83/100
Wide Moat
70+ Wide · 40-69 Narrow · <40 None

Wide moat with strength across all dimensions. Reinvestment Efficiency is the standout factor.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.
HCA
95/100
Wide Moat
70+ Wide · 40-69 Narrow · <40 None

Wide moat with strength across all dimensions. ROIC Consistency is the standout factor.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 5 years of fundamental data.

Forensic Accounting

Learn more →
ABBV
-2.86
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.
HCA
-2.78
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Ownership Breakdown

Learn more →
ABBV
Insiders 0.1%Institutions 76.4%Retail & Other 23.5%
No. of Institutional Holders5,086
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.
HCA
Insiders 16.2%Institutions 78.4%Retail & Other 5.4%
No. of Institutional Holders1,906
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.

High insider ownership aligns management incentives with shareholders. Institutional concentration can indicate smart-money conviction but also crowding risk.

Insider Buying Activity

Learn more →
ABBV
0
Buys (3M)
0
Buys (12M)
No open market insider purchases found.
Open market purchases · includes direct & indirect ownership · excludes option exercises
HCA
0
Buys (3M)
0
Buys (12M)
No open market insider purchases found.
Open market purchases · includes direct & indirect ownership · excludes option exercises

Open market purchases · includes direct & indirect ownership · excludes option exercises.

Insider Selling Activity

Learn more →
ABBV
3
Sells (3M)
6
Sells (12M)
Total value (12M): $34.15M
PURDUE DAVID R.
Officer
$1.22M
@ $233.56 · 2026-03-04
SIATIS PERRY C.
General Counsel
$4.38M
@ $234.39 · 2026-03-02
SIATIS PERRY C.
General Counsel
$5.15M
@ $230.00 · 2026-02-25
SALEKI-GERHARDT AZITA
Chief Operating Officer
$8.41M
@ $198.42 · 2025-08-12
DONOGHOE NICHOLAS
Officer
$2.64M
@ $198.51 · 2025-08-05
STEWART JEFFREY RYAN
Officer
$12.36M
@ $210.08 · 2025-03-31
REENTS SCOTT T.
Chief Financial Officer
$3.75M
@ $212.34 · 2025-03-14
SIATIS PERRY C.
General Counsel
$5.82M
@ $208.69 · 2025-03-03
GONZALEZ RICHARD A
Director
$20.26M
@ $205.45 · 2025-03-03
RICHMOND TIMOTHY J
Officer
$4.47M
@ $210.45 · 2025-03-03
BUCKBEE KEVIN K
Officer
$3.85M
@ $203.41 · 2025-02-26
RICHMOND TIMOTHY J
Officer
$6.07M
@ $202.90 · 2025-02-26
SIATIS PERRY C.
General Counsel
$1.14M
@ $197.90 · 2025-02-20
BUCKBEE KEVIN K
Officer
$310,032
@ $172.24 · 2024-12-16
GONZALEZ RICHARD A
Officer and Director
$12.40M
@ $186.52 · 2024-08-05
GONZALEZ RICHARD A
Officer and Director
$49.50M
@ $175.00 · 2024-07-17
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives
HCA
5
Sells (3M)
8
Sells (12M)
Total value (12M): $38.53M
MCALEVEY MICHAEL R.
Officer
$903,537
@ $533.37 · 2026-02-18
BERRES JENNIFER
Officer
$4.13M
@ $514.58 · 2026-02-11
WYATT CHRISTOPHER F
Officer
$2.02M
@ $505.00 · 2026-02-11
HAZEN SAMUEL N
Chief Executive Officer
$21.48M
@ $501.04 · 2026-02-03
CUFFE MICHAEL S
Officer
$747,135
@ $498.09 · 2026-02-03
MCALEVEY MICHAEL R.
Officer
$1.84M
@ $473.79 · 2025-11-05
CUFFE MICHAEL S
Officer
$1.61M
@ $418.84 · 2025-09-08
FOSTER JON MARK
Officer
$5.80M
@ $369.32 · 2025-05-13
BERRES JENNIFER
Officer
$3.08M
@ $322.59 · 2025-02-14
BILLINGTON PHILLIP G
Officer
$1.36M
@ $350.00 · 2024-11-14
WHALEN KATHLEEN M
Officer
$527,677
@ $357.99 · 2024-11-14
AKDAMAR EROL R
Officer
$1.02M
@ $353.00 · 2024-11-14
CUFFE MICHAEL S
Officer
$3.22M
@ $385.42 · 2024-09-12
WHALEN KATHLEEN M
Officer
$1.76M
@ $362.13 · 2024-07-31
REINER DEBORAH M
Officer
$1.19M
@ $359.96 · 2024-07-29
WYATT CHRISTOPHER F
Officer
$1.44M
@ $360.20 · 2024-07-29
TORRES KATHRYN A
Officer
$659,328
@ $355.05 · 2024-07-25
WHALEN KATHLEEN M
Officer
$1.05M
@ $326.30 · 2024-05-16
TORRES KATHRYN A
Officer
$607,673
@ $326.18 · 2024-05-15
COHEN JEFFREY E.
Officer
$516,450
@ $313.00 · 2024-05-09
CUFFE MICHAEL S
Officer
$2.00M
@ $316.88 · 2024-05-09
CUFFE MICHAEL S
Officer
$494,400
@ $309.00 · 2024-05-06
TORRES KATHRYN A
Officer
$581,256
@ $312.00 · 2024-05-03
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives

Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives.

🎭 Mr. Market's Mood

Learn more →
ABBV
FearGreed
😐Neutral(45/100)

"Market is pricing this stock without strong emotion in either direction"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.
HCA
FearGreed
😐Neutral(53/100)

"Market is pricing this stock without strong emotion in either direction"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

Composite sentiment score based on market signals. Inspired by Buffett’s "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

⚖️ Buffett Signal

Learn more →
ABBV
Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Neutral (45)
HCA
Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Neutral (53)
View ABBV Full AnalysisView HCA Full Analysis
AbbVie Inc. (ABBV) vs HCA Healthcare, Inc. (HCA) Stock Comparison | SafetyMargin.io